Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice to the Annual General Meeting of Revenio Group Corporation

15th Apr 2026 13:00

Revenio Group Corporation | Stock Exchange Release | April 15, 2026 at 16:00:00 EEST

Notice is given to the shareholders of Revenio Group Corporation of the Annual General Meeting to be held on Tuesday May 12, 2026 at 4.00 p.m. at the address Valla Conference Centre, It¤merentori 2, 00180 Helsinki, Finland. Entrance to Valla is via the It¤merenkatu-side entrance, opposite the Ruoholahti metro station. The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 3.00 p.m. Shareholders will be able to follow the meeting via webcast. Instructions for following the meeting via webcast are available on the company's website at https://www.reveniogroup.fi/en/investors/corporate_governance/annual_general_meeting_2026. It is not possible to pose questions, make counterproposals, speak or vote via the webcast. Following the meeting via webcast is not considered as attendance at the Annual General Meeting or as exercising the shareholders’ rights.

After the Annual General Meeting, shareholders will have the opportunity to meet the CEO and members of the Leadership team of Revenio Group Corporation over coffee.

A. MATTERS ON THE AGENDA OF THE GENERAL MEETING

The following matters will be considered at the General Meeting:

1. Opening of the meeting

2. Calling the meeting to order

3. Election of persons to scrutinise the minutes and to supervise the counting of votes

4. Recording the legality of the meeting

5. Recording the attendance at the meeting and adoption of the list of votes

6. Presentation of the financial statements, the report of the Board of Directors and the auditor’s report for 2025

Presentation of the CEO's review.

The financial statements, the report of the Board of Directors and the auditor's report have been available on the company’s website at https://www.reveniogroup.fi/en/investors/corporate_governance/annual_general_meeting_2026 at the latest on March 23, 2026.

7.Adoption of the financial statements

8.Resolution on the use of the profit shown on the balance sheet and the payment of dividendsThe Board of Directors proposes that no dividend for the financial year 2025 will be paid.

In relation to the acquisition announced by stock exchange release on April 13, 2026 and under the share purchase agreement dated April 13, 2026 between the company and the sellers (the “SPA”), the company has undertaken that no dividend payment is proposed prior to the full payment of the deferred purchase price to the sellers. Further, the Board of Directors considers it to be in the best interests of the company and its shareholders to prioritize the allocation of the company’s capital resources to the acquisition, thereby supporting the company’s long-term growth.

9. Resolution on the discharge of the members of the Board of Directors and the CEO from liability

10. Consideration of the remuneration report for governing bodiesThe remuneration report is available on Revenio Group Corporation's website at https://www.reveniogroup.fi/en/investors/corporate_governance/annual_general_meeting_2026. The resolution on the remuneration report is advisory.

11. Amendment of Article 4 of the Articles of AssociationThe Board of Directors proposes that Article 4 of the Articles of Association be amended so that the maximum number of ordinary members of the Board of Directors is increased from seven (7) to eight (8). Following the amendment, the new Article 4 of the Articles of Association would read as follows:

”4 Board of Directors

A Board of Directors comprising no fewer than three (3) and no more than eight (8) ordinary members elected by the Annual General Meeting is responsible for the management of the company and the appropriate organization of its business operations.

A Board member’s term of office ends at the close of the Annual General Meeting following his or her election.

The Board of Directors will elect a Chair from among its members. The Board of Directors is quorate when more than half of its members are present.”

12. Resolution on the remuneration of the members of the Board of Directors and on the grounds for compensation of travel expensesOn the recommendation of the Nomination and Remuneration Committee, the Board of Directors proposes that annual remuneration be paid to the members of the Board of Directors to be elected by the General Meeting for the term of office ending at the close of the Annual General Meeting 2027 as follows: EUR 70,000 to the Chair of the Board, EUR 45,000 to any Vice Chair of the Board, EUR 35,000 to the members of the Board, EUR 15,000 to the Chair of the Audit Committee, EUR 10,000 to the Chair of the Nomination and Remuneration Committee, and EUR 5,000 to the members of the Board committees. In addition to the above, the Chair of a potentially established Technology Committee EUR 10,000 and its members EUR 5,000, as well as the Chair of a potentially established Integration Committee EUR 20,000 and its members EUR 5,000.

On the recommendation of the Nomination and Remuneration Committee, the Board of Directors further proposes that approximately 40 per cent of the annual remuneration (gross) be paid in shares of the company by transferring treasury shares held by the company, however not exceeding a total of 11,200 shares, and the remaining approximately 60 per cent be paid in cash. From the cash portion, tax will be withheld, calculated on the basis of the full amount of the annual remuneration. The shares will be transferred to the members of the Board within two weeks of the publication of Revenio Group Oyj’s half?year financial report for the period 1 Januaryâ€"30 June 2026, using as the value of the share the volume?weighted average trading price on the day following the publication of the half?year financial report.

In addition, on the recommendation of the Nomination and Remuneration Committee, the Board of Directors proposes that meeting fees be paid to the Chairs of the Board and the committees in the amount of EUR 1,000 per meeting for meetings of the Board and the committees and EUR 600 per short remote meeting, and to the members of the Board in the amount of EUR 600 per meeting for meetings of the Board and the committees and EUR 300 per short remote meeting. However, for Chairs of the Board and the committees who reside outside Finland and travel to Finland to attend meetings, the meeting fee for meetings of the Board and the committees shall be EUR 2,000, and for members of the Board the meeting fee for meetings of the Board and the committees shall be EUR 1,200.

Any travel expenses incurred by the members of the Board and the committees shall be reimbursed in accordance with the company’s travel policy.

The Board of Directors proposes that the Board remuneration be paid in accordance with the above to those members conditionally elected to the Board as proposed under item 14, provided that their term of office begins within one month of the resolution of the General Meeting. If the term of office begins thereafter, the Board proposes that annual remuneration be paid in proportion to the length of their term of office compared to that of the other members of the Board, using 12 months as the time basis for the determination of annual remuneration. If the term of office of such Board members begins later than two weeks after the publication of Revenio Group Oyj’s half?year financial report for the period 1 Januaryâ€"30 June 2026, the portion of the remuneration payable in shares shall be transferred to them within two weeks of the commencement of their term of office.

13. Resolution on the number of Members of the Board of DirectorsThe Board proposes, based on the recommendation of the Nomination and Remuneration Committee, that eight (8) members be elected to the Board, of which three (3), who are indicated under item 14, shall be elected conditionally so that their terms of office shall commence only after both of the following conditions have been fulfilled:

The completion (closing) of the acquisition announced by stock exchange release on April 13, 2026, in which the company acquires the entire share capital of the French company LT International SAS, the parent company of the Visionix International group (“Visionix”); and The registration of the amendment to the Articles of Association resolved in agenda item 11 in the Trade Register.

Until the conditions for the commencement of the terms of office of the conditionally elected ordinary members of the Board have been fulfilled, the number of ordinary members of the Board shall be five (5), and after the fulfilment of the conditions, eight (8).

14. Election of the Members of the Board of DirectorsOn the recommendation of the Nomination and Remuneration Committee, the Board of Directors proposes that the current members of the Board, Arne Boye Nielsen, Bill -stman, Riad Sherif, Anat Loewenstein and Heli Lindfors, be re?elected to the Board of Directors.

The Board further proposes that, in relation to the acquisition announced by stock exchange release on April 13, 2026, the following persons be conditionally elected to the Board of Directors: Marc Abitbol, the CEO of Visionix, Charles Vilgrain, Managing Partner of Caravelle Capital SAS, and Nicklas Hansen, Chief Investment Officer at William Demant Invest A/S. The commencement of the terms of office of such persons shall be subject to the following conditions:

the completion (closing) of the acquisition announced by stock exchange release on 13 April 2026, in which the company acquires Visionix; andthe registration of the amendment to the Articles of Association resolved in agenda item 11 in the Trade Register.

All candidates have given their consent to the positions. The conditionally elected candidate Nicklas Hansen is dependent on the company’s significant shareholder William Demant Invest A/S. Otherwise, the candidates are independent of the Company and its significant shareholders.

The company and the Board of Directors acknowledge that, once the terms of office of the conditionally elected members commence, women and men will not be equally represented on the Board of Directors, which deviates from the objective set out in Section 9a of the Finnish Limited Liability Companies Act and from the recommendation of the Finnish Corporate Governance Code issued by the Securities Market Association. The election of the persons conditionally proposed for the Board of Directors is related to the acquisition announced on 13 April 2026, and based on their backgrounds and expertise they have been assessed to be the right and best persons, in the interests of the company and its shareholders, together with the existing members of the Board, to form the Board during the integration phase of the acquisition. The overall proposal has also sought to ensure sufficient continuity in the work of the Board. The company takes seriously the recommendations concerning the equal representation of women and men on the Board of Directors and aims to comply with these recommendations in the future.

William Demant Invest A/S, the largest shareholder of the company, representing approximately 24.48% of the shares as at the date of this notice, has committed to vote in favor of the proposal set out above.

The persons proposed for election to the Board of Directors are presented on the company’s website at https://www.reveniogroup.fi/en/investors/corporate_governance/annual_general_meeting_2026.

15. Resolution on the remuneration of the auditorThe Board of Directors proposes, on the recommendation of the Board’s Audit Committee, that remuneration for the auditor be paid against the auditor’s invoice approved by the company.

16. Election of the AuditorThe Board of Directors proposes, on the recommendation of the Board’s Audit Committee, that authorized public accountants Deloitte Oy, who have named Authorized Public Accountant Mikko Lahtinen as the principal auditor, be elected as the auditor.

17. Authorization of the Board of Directors to decide on the acquisition of own sharesThe Board of Directors proposes that the General Meeting authorize the Board of Directors to resolve on the acquisition of a maximum of 1,334,055 of the company’s own shares in one or more tranches using the company’s unrestricted equity.The company may buy back shares in order to develop its capital structure, finance or implement any corporate acquisitions or other transactions, implement share-based incentive plans, pay board fees or otherwise transfer or cancel them.

The company may buy back shares in public trading on marketplaces whose rules and regulations allow the company to trade in its own shares. In such a case, the company buys back shares through a directed purchase, i.e. in a proportion other than its shareholders’ holdings of company shares, with the consideration paid for the shares based on their publicly quoted market price so that the minimum price of the purchased shares equals the lowest market price quoted in public trading during the authorization period and their maximum price equals the highest market price quoted in public trading during that period.

The authorization is proposed to be effective until the closing of the Annual General Meeting to be held in 2027, yet no further than until June 30, 2027. This authorization will supersede the buyback authorization granted at the Annual General Meeting of April 10, 2025.

18. Authorizing the Board of Directors to decide on a share issue and on granting option rights and other special rights entitling to sharesThe Board of Directors proposes that the Annual General Meeting authorize the Board of Directors to decide on issuing a maximum of 2,668,111 shares in a share issue or on granting special rights (including stock options) entitling holders to shares as referred to in Chapter 10 Section 1 of the Finnish Limited Liability Companies Act, in one or more tranches.

This authorization is proposed to be used to finance and implement any prospective corporate acquisitions or other transactions, to implement the company’s share-based incentive plans, or for other purposes determined by the Board.

The authorization is proposed to grant the Board the right to decide on all terms and conditions governing the share issue and the granting of said special rights, including on the recipients of the shares or special rights and the amount of any payable consideration. The authorization also includes the right to issue shares by deviating from the shareholders’ pre-emptive rights, i.e. in a directed manner. The authorization of the Board covers both the issue of new shares and the assignment of any shares that may be held in the company’s treasury.

The authorization is proposed to be effective until the closing of the Annual General Meeting to be held in 2027, yet no further than until June 30, 2027. This authorization shall supersede the issue authorization decided on at the Annual General Meeting of April 10, 2025.

19. Transaction related share issue authorizationsThe company has announced on April 13 2026, that it has signed an agreement under which it will acquire Visionix (the “Transaction”). The completion of the Transaction is subject to, among others, the General Meeting resolving to authorize the Board of Directors of the company to decide on both a directed issuance of new shares to the sellers in connection with the completion of the Transaction and an issuance of new shares in a planned post-completion rights issue. The proceeds from the rights issue will be used for the repayment of the outstanding bridge facility related to the Transaction.

The following proposals of the Board of Directors form entirety that requires the approval of all its individual items as described below. William Demant Invest A/S, the largest shareholder of the company, representing approximately 24.48% of the shares as at the date of this notice, has committed to vote in favor of these proposals.

19 a) Authorising the Board of Directors to decide on a directed share issueThe Board of Directors proposes that the Annual General Meeting resolves to authorize the Board of Directors to decide on a directed share issue against consideration in which sellers in the Transaction are entitled to subscribe for new shares in the company in deviation from the shareholders’ pre-emptive subscription right (directed share issue). There is a weighty financial reason for deviation of the shareholders’ pre-emptive subscription right as the shares will be issued as part of the purchase price relating to a strategically significant acquisition for the company.

The new shares can be paid by contributing assets to the company (i.e., the sellers’ shares and other securities in the Transaction) in accordance with the SPA (contribution-in-kind). A maximum number of 2,485,797 new shares may be issued in the directed share issue. The Board of Directors is authorized to decide on all the other terms and conditions of the share issue.

The authorization is proposed to be effective until December 31, 2026. The authorization does not revoke other share issue authorizations resolved in the Annual General Meeting.

19 b) Authorizing the Board of Directors to decide on a rights issueThe Board of Directors proposes that the Annual General Meeting authorizes the Board of Directors to resolve on a share issue against consideration in accordance with the shareholders’ pre-emptive rights (rights issue) in one or several tranches so that a maximum number of 14,600,000 new shares in the company may be issued under the authorization, subject to the closing of the Transaction. The number of shares covered by the authorization has been determined taking into account the share issue authorization in section 19 a) (Authorising the Board of Directors to decide on a directed share issue) above.

The Board of Directors is authorized to decide on all the other terms and conditions of the share issue and the Board of Directors have the right to resolve to offer the shares not subscribed by shareholders pursuant to their pre-emptive subscription right for other shareholders or other parties decided by the Board of Directors.

The authorization is proposed to be effective until June 30, 2027. The authorization does not revoke other share issue authorizations resolved in the Annual General Meeting.

20. Establishment of a Shareholders’ Nomination BoardThe Board of Directors proposes that the Annual General Meeting resolve to establish a Shareholders’ Nomination Board, whose responsibility shall going forward be to prepare proposals to the Annual General Meeting for the election of the members of the Board of Directors and the remuneration of the members of the Board of Directors. Additionally, the Board of Directors proposes that the Annual General Meeting approve the charter of the Shareholders’ Nomination Board. The charter of the Shareholders’ Nomination Board proposed by the Board of Directors is available on Revenio Group Corporation’s website at https://www.reveniogroup.fi/en/investors/corporate_governance/annual_general_meeting_2026.

In accordance with the main provisions of the proposed charter, the Shareholders’ Nomination Board shall consist of one representative of each of the company’s four largest shareholders and the Chair of the Board of Directors of the company, who shall act as an expert member. The right to appoint a member belongs to the four shareholders who hold the largest number of votes conferred by all shares in the company, based on the company’s shareholder register on June 30th of the calendar year preceding the next calendar year’s Annual General Meeting. The Chair of the Board of Directors shall request the aforesaid four largest shareholders to each nominate one member to the Nomination Board. In case two shareholders own an equal amount of shares and votes and representatives of both shareholders cannot be appointed to the Nomination Board, the decision shall be made by drawing lots.

If a shareholder does not wish to use their right to appoint a member, the right transfers to the next largest shareholder.

If a shareholder, who has an obligation under the Finnish Securities Markets Act (arvopaperimarkkinalaki) to notify certain changes in ownership (flagging obligation), submits a written request to the Chair of the Board of Directors by June 30th of the calendar year preceding the next calendar year’s Annual General Meeting, the holdings registered in various funds or registers of such a shareholder are combined when calculating the voting rights.

Should a holder of nominee-registered shares wish to use its nomination right, the shareholder shall present a credible report of the number of shares held on June 30th of the calendar year preceding the next calendar year’s Annual General Meeting. The report must be submitted to the Chair of the Board of Directors no later than the eighth banking day of the relevant calendar year in July.The Shareholders’ Nomination Board must submit its proposals to the Board of Directors by January 31st prior to the Annual General Meeting.

The Shareholders' Nomination Board shall be established for the time being, until the General Meeting decides otherwise. The term of the members of the Nomination Board expires annually when the next Nomination Board has been appointed.

21. Consideration of the remuneration policy of the governing bodies (conditional)The remuneration policy is available on Revenio Group Corporation’s website at https://www.reveniogroup.fi/en/investors/corporate_governance/annual_general_meeting_2026. The resolution on the remuneration policy is advisory.

The updates made to the remuneration policy relate in practice primarily to the establishment of the Shareholders’ Nomination Board considered above in item 20, and therefore the consideration of the new remuneration policy is conditional on the Annual General Meeting having decided, in item 20 above, to establish a Shareholders’ Nomination Board.

22. Closing of the Meeting

B. DOCUMENTS OF THE GENERAL MEETING

This notice containing all of the proposed resolutions of the company’s Board of Directors is available on Revenio Group Corporation's website at https://www.reveniogroup.fi/en/investors/corporate_governance/annual_general_meeting_2026. The financial statements, the report of the Board of Directors and the auditor’s report, the remuneration report, the remuneration policy and the proposal of the Board of Directors for the charter of the Shareholders’ Nomination Board of Revenio Group Corporation are available on the above-mentioned website. Copies of these documents and of this notice will be sent to shareholders upon request. The minutes of the Annual General Meeting will be available on the above-mentioned website on May 26, 2026 at the latest.

C. INSTRUCTIONS FOR THE PARTICIPANTS IN THE GENERAL MEETING

1. Shareholders registered in the shareholders’ register

Shareholders who are, on April 29, 2026, registered in the shareholders’ register of the company, maintained by Euroclear Finland, have the right to participate in the General Meeting. Shareholders whose shares are recorded in their personal Finnish book-entry accounts, including equity savings account, are automatically included in the shareholders’ register of the company. Changes in the shareholding after April 29, 2026, do not affect the right to participate in the Annual General Meeting or the shareholder's voting rights.

The registration period for the General Meeting commences on April 15, 2026 at 4.00 p.m. EEST. Shareholders registered in the shareholders’ register of the company, who wish to attend the General Meeting, must register for the Meeting, no later than by 3 p.m. on May 5, 2026, by which time the registration must be received. Registration for the General Meeting takes place:

a) via the company's website at https://www.reveniogroup.fi/en/investors/corporate_governance/annual_general_meeting_2026. Electronic registration requires strong identification of the shareholder or their legal representative or proxy with a Finnish, Swedish, or Danish bank ID, or a mobile certificate.

b) by e-mail. Shareholders registering by e-mail shall submit the registration form available on the company's website https://www.reveniogroup.fi/en/investors/corporate_governance/annual_general_meeting_2026 or equivalent information to: [email protected]

c) by mail. Shareholders registering by mail shall submit the registration form available on the company's website https://www.reveniogroup.fi/en/investors/corporate_governance/annual_general_meeting_2026 or equivalent information to Innovatics Oy, General Meeting / Revenio Group Plc, Ratamestarinkatu 13 A, FI-00520 Helsinki, Finland

The shareholder and their representative are required to provide information, such as the shareholder's name, date of birth or business ID, phone number and/or e-mail, address, the name of any assistant or proxy representative and the proxy's date of birth, phone number and/or e-mail. The personal data provided to Revenio Group Corporation is only used in connection with the General Meeting and the processing of the necessary registrations related thereto.

The shareholder and their representative or proxy must be able to prove their identity and/or right of representation at the meeting.

Further information on registration is available by telephone during the registration period of the General Meeting by calling Innovatics Oy at +358 10 2818 909 on weekdays from 9:00 a.m. to 12:00 p.m. and from 1:00 p.m. to 4:00 p.m.

2. Holders of nominee-registered shares

A holder of nominee-registered shares is entitled to participate in the General Meeting based on the shares, which would entitle them entry into the shareholders' register held by Euroclear Finland Oy on the record date for the General Meeting April 29, 2026. Participation also requires that the shareholder is temporarily registered in the shareholders' register held by Euroclear Finland Oy by May 7, 2026 by 10.00 a.m. at the latest. In the case of nominee-registered shares, this is considered as registration for the General Meeting. Changes in the shareholding after the record date of the General Meeting do not affect the right to participate in the General Meeting or the shareholder's voting rights.

A holder of nominee-registered shares is advised to request well in advance the necessary instructions from their custodian bank regarding temporary registration in the register of shareholders, the issuing of proxy documents and voting instructions, registration, and attendance at the General Meeting. The account manager of the custodian bank shall register the holder of nominee-registered shares who wishes to participate in the General Meeting temporarily in the register of shareholders of the company by the aforementioned date and time at the latest. Further information is also available on the company's website at https://www.reveniogroup.fi/en/investors/corporate_governance/annual_general_meeting_2026.

3. Proxy representative and proxy documents

A shareholder may attend the General Meeting and exercise their rights at the Meeting through a proxy representative. The proxy representative must authenticate to the electronic registration service personally with strong authentication, after which they will be able to register on behalf of the shareholder, who they represent. The shareholder's proxy must present dated proxy documents, or otherwise in a reliable manner prove that they are entitled to represent the shareholder at the General Meeting.

Shareholders can also use the electronic Suomi.fi authorization service instead of a traditional proxy document. In such cases, the shareholder authorizes a proxy that they nominate in the Suomi.fi authorization service at www.suomi.fi/e-authorizations using the mandate theme “Representation at the General Meeting”. At the service, the authorized person must identify themselves using strong electronic identification in connection with their registration, after which the electronic authorization will be checked automatically. Strong electronic identification can be done using online banking codes or Mobile ID. More information is available on the website www.suomi.fi/e-authorizations.

Model proxy documents and voting instructions are available on the company's website https://www.reveniogroup.fi/en/investors/corporate_governance/annual_general_meeting_2026. If a shareholder participates in the General Meeting through several proxies representing the shareholder with shares held in different securities accounts, the shares on the basis of which each proxy represents the shareholder shall be identified in connection with the registration.

Any proxy documents are requested to be submitted preferably as an attachment with the electronic registration or alternatively by mail to Innovatics Oy, General Meeting / Revenio Group Corporation, Ratamestarinkatu 13 A, FI-00520 Helsinki, Finland or by e-mail to [email protected] before the end of the registration period. In addition to submitting the proxy documents, the shareholder or their proxy shall register for the General Meeting in the manner described above in this notice.

4. Following the General Meeting remotely

A shareholder who is entitled to attend the General Meeting may also follow the meeting remotely.

It is not possible to pose questions, make counterproposals, speak or vote via the webcast. Following the meeting via webcast is not considered as attendance at the Annual General Meeting or as exercising the shareholders’ rights.

Remote access to the General Meeting will be provided through Inderes Oyj virtual general meeting service on the Videosync platform, which includes video and audio access to the General Meeting. Remote access does not require any paid software or downloads. In addition to an internet connection, remote access requires a computer, smartphone or tablet with speakers or headphones for sound. One of the following browsers is recommended for remote access: Chrome, Firefox, Edge, Safari, or Opera. It is advisable to log in to the meeting system well in advance of the meeting.

The link and password for following the meeting remotely will be sent by e-mail and/or SMS to the e-mail address and/or mobile phone number provided at the time of registration to all those who have registered for the General Meeting no later than the day before the General Meeting.

For more information on the general meeting service, additional instructions for proxies representing more than one shareholder, contact details of the service provider and instructions in case of possible disruptions can be found here https://vagm.fi/support. A link to test the compatibility of your computer, smartphone or tablet with the network connection can be found here: https://b2b.inderes.com/knowledge-base/compatibility-testing. It is recommended that you read the detailed instructions before the meeting.

5. Other instructions and information

The meeting language is mainly Finnish and simultaneous interpretation is provided at the meeting into English and, where necessary, into Finnish for presentations in English. Simultaneous interpretation is also available to shareholders following the general meeting via webcast.

Shareholders arriving at the meeting with their car are asked to note that parking in the vicinity of the meeting place is subject to a fee.

Pursuant to Chapter 5 Section 25 of the Limited Liability Companies Act, a shareholder who is present at the General Meeting has the right to request information with respect to the matters to be considered at the meeting.

On the date of this notice of the General Meeting, April 15, 2026, the total number of shares in Revenio Group Corporation, and votes represented by such shares, is 26,681,116. The company holds on April 15. 2026, a total of 75,850 of its own shares which are not entitled to vote at the General Meeting.

In Vantaa on April 15, 2026

REVENIO GROUP CORPORATIONBOARD OF DIRECTORS

For further information, please contactCEO Jouni Toijala, tel. +358 484 0085[email protected]DistributionNasdaq Helsinki OyFinancial Supervisory Authority (FIN-FSA)Main mediawww.reveniogroup.fi/enRevenio Group in briefRevenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, microperimeters, and perimeters as well as software solutions under the iCare brand.In 2025, the Group’s net sales totaled EUR 109.7 million, with an operating profit of EUR 25.4 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments


Notice to the Annual General Meeting of Revenio Group Corporation

FTSE 100 Latest
Value10,559.58
Change-49.48